+91- 99099 19545
info@accuprec.com
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for YUPELRITM (revefenacin) inhalation solution for the maintenance treatment of...
Read More
Prof. R.K. Goyal, Vice Chancellor, Delhi Pharmaceutical Sciences and Research University, Awarded Prof. M.L. Schroff Award during 23rd APTICON-2018 held on Oct 5-6, 2018 at Jaipur. Dr. Sushama Talegaonkar Associate Professor, Pharmaceutics and Dr. Mukesh Nandave, Associate Professor in Pharmacology...
Read More
Bangalore-based company to sell migraine drug SUD-001H in US market Strides Pharma Science (formally Strides Shasun) on Friday said its step-down subsidiary has entered into an exclusive product development, licensing and supply agreement with Australia’s SUDA Pharmaceuticals for its drug...
Read More
Sohini Das | Mumbai Zydus Wellness, the personal care arm of pharma major Cadila Healthcare, is planning to use its doctor connect to boost the sales of the acquired brands portfolio of Heinz India. Analysts expect the acquisition to be...
Read More
Ministry of Food Processing Industries(MoFPI) under Union Minister Smt Harsimrat Kaur Badal has approved the operationalisation strategy for Operation Greens today. Operation Greens was announced in the Budget speech of 2018-19 with an outlay of Rs 500 crores to stabilize...
Read More
Pharma major Lupin announced the launch of Atovaquone Oral Suspension USP, 750 mg/5 mL having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Atovaquone Oral Suspension USP, 750 mg/5 mL is the generic equivalent...
Read More
Roche has announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) plus chemotherapy (Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of unresectable...
Read More
A Memorandum of Understanding (MoU) for the partnership between Department of Biotechnology and Cancer Research UK for the India-UK India-UK Cancer Research Initiative was signed today in New Delhi.The India-UK Cancer Research Initiative is a collaborative 5-year bilateral research initiative...
Read More
“The Health Ministry has taken up several focused and targeted schemes for addressing nutrition challenges in the country in a convergence mode with the other Ministries.We have focussed on Immunisation, detection and supplementation.” This was stated by Shri J P...
Read More
Accuprec Research Labs Pvt. Ltd. © 2024
